Custom packaging
What buyers want to believe on shelf.
Tell us what you are packing, the pouch style you want, and how many versions you need. Sparal can help match pharma & medical with the right material, finish, proof plan, and order quantity.
Market / Pharma and Medical
Custom pharmaceutical and medical pouch packaging: sterile-grade production, high-barrier foil laminates, and both rotogravure and digital print under one roof.

Interactive 3D
Spin a real stand up pouch model — the same dieline your artwork prints on. Matte, gloss, foil, kraft, and window directions render live, so you can judge shelf presence before you ever request a proof.
Custom packaging
Tell us what you are packing, the pouch style you want, and how many versions you need. Sparal can help match pharma & medical with the right material, finish, proof plan, and order quantity.
Use cases
Why brands choose it
The shelfClinical formats, three products
See the gallery →Market decision map
Sterile-grade capable production, high-barrier foil structures, and dual-process printing — digital for trials, rotogravure for validated volume.
Quote signal: Product and dose format, barrier target, lot sizes by phase, regulatory context, and documentation needs.

Barrier and process reading
The decisions that matter before a pharmaceutical or medical pouch program is priced.
Ordering path
Follow the next decisions in order: market, format, material, planning tool, risk check, and pricing request.
Quote details
High-barrier foil laminates with moisture, oxygen, and light protection; sealing parameters documented per structure
01 / Market
Start with pharma & medical buyer expectations and the first shelf objection.
02 / Format
Foil sachets, flat 3-side-seal pouches, stand-up pouches, and high-barrier laminate bags for powders, tablets, devices, and single-...
03 / Material
High-barrier foil laminates with moisture, oxygen, and light protection; sealing parameters documented per structure
04 / Tool
Low MOQ pouches
05 / Quote
Digital and rotogravure under one roof — trial lots and validated volume without switching suppliers.
Send these details when you are ready for pricing, samples, or production guidance.
Get pricingPackaging signals
Use these notes to turn material, MOQ, artwork, and launch timing into a clearer quote.
01 / Comparison
Digital-only pouch suppliers fit trials and small lots, but validated pharma programs eventually want rotogravure economics and consistency. Running both processes in-house means the same packaging program can move from a 100-piece trial lot to validated volume without requalifying a new supplier.
Shelf strategy
Use this section to choose format, material, artwork, quantity, and proof details before you ask for pricing.
01
The pack should immediately communicate clinical trial kits, sample and starter packs, and why the product belongs in the set.
02
Sterile-grade capable production; both rotogravure and digital print in-house — method matched to lot size and validation stage. Material should follow the product's real shelf-life and handling risk.
03
Sterile-grade capable production with documented seal parameters.
Buyer objection
01
Clinical trial kits, Sample and starter packs, Nutraceutical launches
02
Sterile-grade capable production; both rotogravure and digital print in-house — method matched to lot size and validation stage. Make the pack answer that concern fast.
03
Stand-up, flat-bottom, spout, window, or high-barrier structures by product need. Use product photos and gallery examples as the starting point for shelf direction.
Made in-house
Production record · first-partyThese are our own presses, films, and converting line — the equipment behind every quote.

Sparal prints on an HP Indigo 6900 digital press — no printing plates, so every SKU and short run prints without per-design plate fees.
No plates · no per-design plate fees
Shot on our line · © Sparal Packaging

Foil and metallized film stock staged on the converting line for high-barrier pouches.
Shot on our line · © Sparal Packaging

Inside production: printing, lamination, slitting, and pouch converting for custom flexible packaging.
Shot on our line · © Sparal Packaging
What to send
Send Product type, dose or fill format, barrier target, regulatory context, lot sizes by phase, artwork status, and documentation needs. If some details are open, we can help narrow the material, finish, and proof path.

Common formats
Foil sachets, flat 3-side-seal pouches, stand-up pouches, and high-barrier laminate bags for powders, tablets, devices, and single-dose formats
Production
Sterile-grade capable production; both rotogravure and digital print in-house — method matched to lot size and validation stage
MOQ
Digital runs from 100+ pouches per SKU for trials and samples; rotogravure quoted for validated volume programs
Material needs
High-barrier foil laminates with moisture, oxygen, and light protection; sealing parameters documented per structure
Quote detail
Product type, dose or fill format, barrier target, regulatory context, lot sizes by phase, artwork status, and documentation needs
Buyer questions
01
Yes — sterile-grade capable production is available. Requirements, specifications, and documentation are confirmed per project at quote, since pharmaceutical programs vary by product and regulatory context.
02
Digital fits trials, samples, and small validated lots — no plates, fast artwork changes. Rotogravure fits long validated runs where unit economics and repeat consistency dominate. We run both, so the answer can change as your program scales without changing suppliers.
03
High-barrier foil laminates are the usual starting point — moisture, oxygen, and light protection for tablets, powders, and devices. The exact structure is specified to your product and stability requirements.
04
Product type and dose format, barrier and stability targets, lot sizes by phase (trial, launch, validated volume), regulatory context, artwork status, and the documentation you need from the producer.
More options

Ready to build?
Send formats, quantities, artwork count, and target timeline. We will map the fastest low-risk path to proof, production, and the reorder that should come next.
